<< Back to News

New HCPCS Code for BLINCYTO®

The Centers for Medicare & Medicaid Services (CMS) assigned a HCPCS code for BLINCYTO® which became effective on January 1, 2016.  

 

HCPCS Code

BLINCYTO Long Descriptor

Effective Date

J9039

Injection, blinatumomab, 1mcg

1/1/2016

Source: Centers for Medicare and Medicaid Services Alpha-Numeric HCPCS File

Source Link: CMS 2016 Alpha-Numeric HCPCS File

 

BLINCYTO was approved by the US Food and Drug Administration on December 3, 2014, for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).  This indication is approved under accelerated approval. Continued approval for this indication may be contingent upon verification of clinical benefit in subsequent trials.